{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:37Z","timestamp":1791923917265,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.tem.2008.01.006","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T15:47:03Z","timestamp":1205250423000},"page":"88-90","source":"Crossref","is-referenced-by-count":177,"title":["Primary aldosteronism: cardiovascular, renal and metabolic implications"],"prefix":"10.1016","volume":"19","author":[{"given":"Gian-Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberta","family":"Giacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Strazzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Funder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2008.01.006_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tem.2008.01.006_bib2","first-page":"S147","article-title":"Left ventricular systolic function in primary aldosteronism and hypertension","volume":"19","author":"Rossi","year":"1997","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2008.01.006_bib3","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2008.01.006_bib4","first-page":"357","article-title":"Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism","volume":"7","author":"Rossi","year":"1993","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2008.01.006_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.31.1.335","article-title":"Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure","volume":"31","author":"Rizzoni","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2008.01.006_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","article-title":"Relations between cardiac and vascular structure in patients with primary and secondary hypertension","volume":"32","author":"Rizzoni","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tem.2008.01.006_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08037059209077510","article-title":"Fibrosis of the human heart and systemic organs in adrenal adenoma","volume":"1","author":"Campbell","year":"1992","journal-title":"Blood Press."},{"key":"10.1016\/j.tem.2008.01.006_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2008.01.006_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin","volume":"41","author":"Kozakova","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2008.01.006_bib10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00004872-200207000-00032","article-title":"Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension","volume":"20","author":"Muiesan","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2008.01.006_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissue","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2008.01.006_bib12","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2008.01.006_bib13","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism Type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2008.01.006_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI111349","article-title":"Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension","volume":"73","author":"Dworkin","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2008.01.006_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.RES.0000106135.02935.E1","article-title":"Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone","volume":"93","author":"Uhrenholt","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2008.01.006_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.HYP.10.1.11","article-title":"Renal function curve in patients with secondary forms of hypertension","volume":"10","author":"Kimura","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2008.01.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2008.01.006_bib18","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/en.2005-1527","article-title":"Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in DOC\/salt rats","volume":"147","author":"Lam","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2008.01.006_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type-2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2008.01.006_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2008.01.006_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism. Results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2008.01.006_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2008.01.006_bib23","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.tem.2008.01.006_bib24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2008.01.006_bib25","unstructured":"Nagase, M. et al. Salt-induced nephropathy in obese SHR via paradoxical activation of mineralocorticoid receptor: role of oxidative stress. Hypertension (in press)"},{"key":"10.1016\/j.tem.2008.01.006_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tem.2008.01.006_bib27","first-page":"414","article-title":"Decreased insulin receptor number and affinity in subcutaneous adipose tissue in a patient with primary hyperaldosteronism","volume":"188","author":"Carranza","year":"1991","journal-title":"Rev. Clin. Esp."},{"key":"10.1016\/j.tem.2008.01.006_bib28","first-page":"755","article-title":"Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism","volume":"8","author":"Shimamoto","year":"1994","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2008.01.006_bib29","first-page":"21","article-title":"Insulin action in primary aldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tem.2008.01.006_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33549\/physiolres.930000.49.241","article-title":"Impaired insulin action in primary aldosteronism","volume":"49","author":"Widimsky","year":"2000","journal-title":"Physiol. Res."},{"key":"10.1016\/j.tem.2008.01.006_bib31","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2008.01.006_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2008.01.006_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2008.01.006_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2002-030024","article-title":"Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICK1 indexes in subjects with different endocrine disorders","volume":"89","author":"Skrha","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2008.01.006_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","article-title":"Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?","volume":"50","author":"Widimsky","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.tem.2008.01.006_bib36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Smiley","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2008.01.006_bib37","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 23, S4\u2013S19"}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276008000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276008000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:52:31Z","timestamp":1738115551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276008000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1043276008000295"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2008.01.006","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}